These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7852486)

  • 1. Therapeutic controversies. Radioiodine may be bad for Graves' ophthalmopathy, but...
    Pinchera A; Bartalena L; Marcocci C
    J Clin Endocrinol Metab; 1995 Feb; 80(2):342-5. PubMed ID: 7852486
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic controversies. Radioiodine therapy does not aggravate Graves' ophthalmopathy.
    Gorman CA
    J Clin Endocrinol Metab; 1995 Feb; 80(2):340-2. PubMed ID: 7852485
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic controversies. Summation, commentary, and overview: concerns over aggravation of Graves' ophthalmopathy by radioactive iodine treatment and the use of retrobulbar radiation therapy.
    Wartofsky L
    J Clin Endocrinol Metab; 1995 Feb; 80(2):347-9. PubMed ID: 7852488
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy.
    DeGroot LJ; Gorman CA; Pinchera A; Bartalena L; Marcocci C; Wiersinga WM; Prummel MF; Wartofsky L; Marocci C [corrected to Marcocci C]
    J Clin Endocrinol Metab; 1995 Feb; 80(2):339-40. PubMed ID: 7677823
    [No Abstract]   [Full Text] [Related]  

  • 5. Does radioiodine cause the ophthalmopathy of Graves' disease?
    McDougall IR
    Nucl Med Commun; 1993 Feb; 14(2):79-81. PubMed ID: 8429998
    [No Abstract]   [Full Text] [Related]  

  • 6. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine ophthalmopathy and radioiodine therapy.
    Karlsson FA
    Acta Oncol; 2006; 45(8):1046-50. PubMed ID: 17118837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine therapy and Graves' ophthalmopathy.
    Bartalena L
    Nucl Med Commun; 2002 Nov; 23(11):1143-5. PubMed ID: 12411845
    [No Abstract]   [Full Text] [Related]  

  • 9. Radioiodine and Graves' ophthalmopathy reconsidered.
    Noury AM; Stanford MR; Graham EM
    Nucl Med Commun; 2001 Nov; 22(11):1167-9. PubMed ID: 11606880
    [No Abstract]   [Full Text] [Related]  

  • 10. Graves' ophthalmopathy and 131I therapy.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
    Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (131)I and thyroid-associated ophthalmopathy.
    Rasmussen AK; Nygaard B; Feldt-Rasmussen U
    Eur J Endocrinol; 2000 Aug; 143(2):155-60. PubMed ID: 10913933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioiodine associated de novo Graves' opthalmopathy in an Asian cohort.
    Tay WL; Tong AKT; Hui KYD; Tang YLC; Chng CL
    Hell J Nucl Med; 2017; 20(3):227-231. PubMed ID: 29177260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioiodine therapy and Graves' ophthalmopathy.
    Bartalena L; Marcocci C
    Thyroid; 1996 Jun; 6(3):253. PubMed ID: 8837336
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of a subgroup of Graves' disease patients at higher risk for severe ophthalmopathy after radioiodine.
    Barth A; Probst P; Bürgi H
    J Endocrinol Invest; 1991 Mar; 14(3):209-12. PubMed ID: 2071823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioiodine therapy and Graves' ophthalmopathy.
    Spitzweg C; Rossmüller B; Heufelder AE
    Thyroid; 1998 Dec; 8(12):1193. PubMed ID: 9920377
    [No Abstract]   [Full Text] [Related]  

  • 16. [Paradoxical effect of radioiodine therapy in functional thyroid autonomy and mild immunothyropathy].
    Dunkelmann S; Rudolph F; Prillwitz A; Groth P; Schümichen C
    Nuklearmedizin; 1998 Jan; 37(1):23-9. PubMed ID: 9467166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing Graves' ophthalmopathy.
    Wiersinga WM
    N Engl J Med; 1998 Jan; 338(2):121-2. PubMed ID: 9420345
    [No Abstract]   [Full Text] [Related]  

  • 18. Graves' disease and thyroid associated ophthalmopathy following radioiodine therapy in euthyroid multinodular goiter.
    Munigoti S; Samat A; Keston Jones M
    Thyroid; 2008 May; 18(5):585. PubMed ID: 18466082
    [No Abstract]   [Full Text] [Related]  

  • 19. Neonatal hyperthyroidism in the offspring of mothers with Graves' disease treated with radioiodine.
    García García E; Porras Cantarero JA; Fernández López P; Domínguez Gutiérrez de Ceballos R; Domínguez Pascual I
    Endocrinol Nutr; 2013 Nov; 60(9):e31-2. PubMed ID: 23490308
    [No Abstract]   [Full Text] [Related]  

  • 20. [Graves' disease nd toxic nodular goiter--radioiodine therapy].
    Schicha H; Dietlein M
    Nuklearmedizin; 2002 Apr; 41(2):63-70. PubMed ID: 11989300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.